Azerutamig is a bispecific monoclonal antibody that simultaneously targets KLRK1 (NKG2D) and ERBB2 (HER2). Based on a scFv-Fc architecture, this antibody facilitates immune cell redirection and cytotoxicity toward HER2-positive tumor cells expressing NKG2D ligands. Azerutamig is suitable for research in cancer immunotherapy and bispecific antibody engineering..
Azerutamig is a bispecific monoclonal antibody that simultaneously targets KLRK1 (NKG2D) and ERBB2 (HER2). Based on a scFv-Fc architecture, this antibody facilitates immune cell redirection and cytotoxicity toward HER2-positive tumor cells expressing NKG2D ligands. Azerutamig is suitable for research in cancer immunotherapy and bispecific antibody engineering..
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: